Spots Global Cancer Trial Database for ebv positive t cell lymphoma
Every month we try and update this database with for ebv positive t cell lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas | NCT05011058 | Epstein-Barr Vi... EBV-Related PTL... EBV Related Non... EBV-Positive DL... EBV Associated ... EBV Related PTC... | Nanatinostat in... | 18 Years - | Viracta Therapeutics, Inc. | |
An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas | NCT05011058 | Epstein-Barr Vi... EBV-Related PTL... EBV Related Non... EBV-Positive DL... EBV Associated ... EBV Related PTC... | Nanatinostat in... | 18 Years - | Viracta Therapeutics, Inc. |